Routine Tumor Testing for Homologous Recombination Deficiency in Patients With High Grade Epithelial Ovarian Cancer at a Statewide Gynecological Cancer Service in Western Australia: An Observational Study

ABSTRACT Background Poly‐ADP ribose polymerase inhibitors have been shown to improve progression‐free survival in patients with advanced high‐grade epithelial non‐mucinous ovarian cancers characterized by a deficiency in homologous recombination (HRD). Guidelines recommend all patients with advanced...

詳細記述

書誌詳細

主要な著者:	Kaamini Planisamy, Elena Ctori, Benhur Amanuel, Emma R. Allanson, Chloe Ayres, Martin Buck, Giselle Howard, Yee Leung, Tarek Meniawy, G. Raj K. A. Mohan, Cassandra B. Nichols, Navin David Pallayoor, Paul A. Cohen
フォーマット:	Artigo
言語:	Inglês
出版事項:	Wiley 2025-09-01
シリーズ:	Cancer Reports
主題:	homologous recombination deficiency (HRD) HRD testing ovarian cancer poly‐ADP ribose polymerase inhibitors
オンライン･アクセス:	https://doi.org/10.1002/cnr2.70335
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!